Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice

Gut

Volumn 40, Issue 1, 1997, Pages 133-138

  Bruck, R ^a   Shirin, H ^a   Hershkoviz, R ^b   Lider, O ^b   Kenet, G ^a   Aeed, H ^a   Matas, Z ^a   Zaidel, L ^a   Halpern, Z ^a  

^a E Wolfson Medical Centre   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Arg Gly Asp acid; Concanavalin A; Cytokines; Hepatitis; RGD mimetics; T lymphocytes

Indexed keywords

CONCANAVALIN A; CYTOKINE; INTERLEUKIN 6; SF 6,5; SF 6,6; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEPATITIS; HISTOLOGY; IMMUNOMODULATION; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031049463     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.1.133     Document Type: Article

References (16)

1. Tiegs G, Hentchel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by Concanavalin A. J Clin Invest 1992; 90: 196-203.
2. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995; 21: 190-8.
3. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994; 179: 1529-37.
4. Hershkoviz R, Lider O, Bruck R, Aeed H, Greenspoon N, Halpern Z. Treatment of immune cell-mediated liver damage by nonpeptidic mimetics of the extracellular matrix-associated Arg-Gly-Asp epitope. J Hepatol 1995; 22: 158-64.
5. Czaja MJ, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 1995; 108: 1849-54.
6. Hershkoviz R, Greenspoon N, Mekori YA, Hadari R, Alon R, Lider O. Inhibition of CD4+ T lymphocyte binding to fibronectin and immune-cell accumulation in inflammatory sites by novel peptidic mimetics of the Arg-Gly-Asp cell adhesion motif. Clin Exp Immunol 1994; 95: 270-6.
7. Hardan I, Hershkoviz R, Greenspoon N, Weiss I, Alon R, Cahalon L, et al. Inhibition of metastatic cell colonization in murine lungs and tumor-induced morbidity by non-peptidic mimetics of the Arg-Gly-Asp motif. Int J Cancer 1993; 55: 1-6.
8. Greenspoon N, Hershkoviz R, Alon R, Varon D, Shemkman B, Marx G, et al. Selective inhibition of integrin-mediated platelet and T cell function by novel organic surrogates of the Arg-Gly-Asp cell adhesion motif. Biochemistry 1993; 32: 1001-8.
9. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen Staphylococal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 1992; 175: 91-8.
10. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-34.
11. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
12. Ruoslahti E. Integrins. J Clin Invest 1991; 87: 1-5.
13. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem 1988; 57: 375-93.
14. D'Souza SE, Ginsberg MH, Plow EF. Arginyl-Glycil-Aspartic acid (RGD): a cell adhesion motif. TIBS 1991; 16: 246-50.
15. Shimuzu Y, van Seventer GA, Horgan KJ, Shaw S. Regulated expression and binding of three VLA (β1) integrin receptors on T cells. Nature 1990; 345: 250-3.
16. Ferguson TA, Mizutani H, Kupper TS. Two integrin-binding peptides abrogate T cell-mediated immune responses in viva. Proc Natl Acad Sci USA 1991; 88: 8072-6.